Close Menu

research consortium

The partners will collaborate on pediatric oncology research, with a goal of earning an NCI designation of Comprehensive Cancer Center.

Thirteen institutions and life sciences companies have teamed up to launch the free repository that will offer access to allele frequency information from genomes and exomes.

The Australian bioinformatics firm will contribute to developing international standards for integrated genomic and clinical data aggregation and sharing.

The National Access Project, led by the Personalized Medicine Initiative and Contextual Genomics, aims to provide tumor profiling for 2,000 Canadians. 

The contribution will support research projects to develop molecular probes to study epigenetic mechanisms of gene regulation.

The partners created a consortium that will perform a metagenomics study into the role that microorganisms play in a "normal, safe factory environment." 

Illumina and collaborators from several consortia have developed a new genotyping microarray optimized for genome-wide association studies in populations of diverse ancestries and backgrounds.

Caprion, Asuragen, and the AIT Austrian Institute of Technology join the consortium launched in 2013 to develop blood-based tests for the early detection of cancers.

NEW YORK (GenomeWeb) – Cartagenia announced today that it and Qiagen's bioinformatics business are part of a consortium that has received €1.4 million ($1.7 million) in funding from a European funding initiative to support the development of software tools for personalized genetic analysis of can

NEW YORK (GenomeWeb) – The GPCR Consortium was launched today with the goal of generating high-resolution pictures of G-protein coupled receptors.

Pages

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.